To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UCHL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
471 representative clones for gene UCHL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR613951 fetal brain .a 1 to 1546 5 to 1550 exact tiling clone,   1550/1550
(100 %)
0 diff
(100 %id)
BX419997 brain, fetal brain .a 1 to 876 5 to 875   fully sequenced,   875/875
(100 %)
5 diff
(99.5 %id)
BX455385 brain, fetal brain .a 815 to 1546 737 to 1   fully sequenced,   737/737
(100 %)
4 diff
(99.5 %id)
CN483295 eye .b 1 to 557 17 to 574   tiling clone,   556/574
(96 %)
7 diff
(98.8 %id)
CR605906 fetal brain .b 28 to 1092 1 to 1065       1065/1065
(100 %)
0 diff
(100 %id)
BG708711 brain, hypothalamus .b 40 to 860 1 to 823       821/823
(99 %)
20 diff
(97.6 %id)
BG716214 brain, hypothalamus .b 40 to 781 1 to 744       742/744
(99 %)
14 diff
(98.2 %id)
BG716255 brain, hypothalamus .b 40 to 862 1 to 828       826/828
(99 %)
20 diff
(97.6 %id)
BI601106 brain, hypothalamus .b 40 to 599 1 to 574       572/660
(86 %)
29 diff
(95.7 %id)
DB491709 hypothalamus .b 45 to 484 1 to 441       439/441
(99 %)
17 diff
(96.2 %id)
TI_45214230   .b 45 to 599 86 to 654       567/740
(76 %)
27 diff
(96.4 %id)
TI_154016685   .b 46 to 927 57 to 922     Submitted on the opposite strand 864/1050
(82 %)
44 diff
(95.9 %id)
BM702238 eye, optic nerve .b 47 to 648 1 to 603       603/603
(100 %)
14 diff
(97.7 %id)
DB503339 hypothalamus .b 48 to 535 1 to 489       487/489
(99 %)
7 diff
(98.6 %id)
DB506263 hypothalamus .b 48 to 520 1 to 474       472/474
(99 %)
5 diff
(99.0 %id)
DB506377 hypothalamus .b 48 to 518 1 to 472       470/472
(99 %)
6 diff
(98.8 %id)
BI601250 brain, hypothalamus .b 51 to 806 11 to 666       495/854
(57 %)
26 diff
(97.0 %id)
TI_45211279   .b 51 to 806 176 to 831       495/1019
(48 %)
26 diff
(97.5 %id)
TI_154190249   .b 56 to 860 50 to 844       793/880
(90 %)
18 diff
(98.0 %id)
CR623179 neuroblastoma .b 57 to 1116 1 to 1060       1060/1060
(100 %)
0 diff
(100 %id)
CF127130 Chondrosarcoma Lung Metastasis cell lines, lung .b 57 to 841 1 to 778       776/779
(99 %)
15 diff
(98.1 %id)
CR598723 B cells (Ramos cell line) .b 59 to 1072 1 to 1014       1014/1014
(100 %)
0 diff
(100 %id)
CR609313 fetal brain .b 59 to 1081 1 to 1023       1023/1023
(100 %)
0 diff
(100 %id)
CR614782 neuroblastoma .b 59 to 1146 1 to 1088   tiling clone,   1088/1088
(100 %)
0 diff
(100 %id)
CR616949 B cells (Ramos cell line) Cot 25-normalized .b 59 to 1091 1 to 1033       1033/1033
(100 %)
0 diff
(100 %id)
CR623929 Neuroblastoma Cot 25-normalized .b 59 to 1095 1 to 1037       1037/1037
(100 %)
0 diff
(100 %id)
CR591761 neuroblastoma .b 60 to 1096 1 to 1037       1037/1037
(100 %)
0 diff
(100 %id)
CR619178 fetal brain .b 60 to 1105 1 to 1046       1046/1046
(100 %)
0 diff
(100 %id)
CR596405 fetal brain .b 66 to 1076 1 to 1011       1011/1011
(100 %)
0 diff
(100 %id)
CR624065 adult brain .b 66 to 1100 1 to 1035       1035/1035
(100 %)
0 diff
(100 %id)
BG170958 hypernephroma, cell line, Kidney .b 67 to 855 1 to 807       655/926
(70 %)
80 diff
(91.4 %id)
CR626014 B cells (Ramos cell line) Cot 25-normalized .b 75 to 1089 1 to 1015       1015/1015
(100 %)
0 diff
(100 %id)
BE266162 lung, small cell carcinoma .b 75 to 678 1 to 616       614/726
(84 %)
21 diff
(97.2 %id)
CR595667 B cells (Ramos cell line) Cot 25-normalized .b 77 to 1088 1 to 1012       1012/1012
(100 %)
0 diff
(100 %id)
BE394134 endometrium, adenocarcinoma cell line, uterus .b 77 to 558 1 to 482       480/486
(98 %)
12 diff
(97.6 %id)
AW247628 lung, small cell carcinoma .b 82 to 654 5 to 579     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 573/579
(98 %)
15 diff
(97.5 %id)
CR610993 fetal brain .b 87 to 1117 1 to 1031       1031/1031
(100 %)
0 diff
(100 %id)
D52742   .b 96 to 461 1 to 370       364/370
(98 %)
14 diff
(96.3 %id)
TI_154115686   .b 258 to 1119 937 to 89   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 849/968
(87 %)
24 diff
(97.6 %id)
W31273 lung .b 264 to 477 1 to 222       222/222
(100 %)
16 diff
(92.8 %id)
CD618120   .b 265 to 1035 795 to 20       776/809
(95 %)
9 diff
(98.9 %id)
BG205587   .b 267 to 1041 1 to 764       764/765
(99 %)
46 diff
(94.0 %id)
TI_149284615   .b 283 to 1119 907 to 71   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 837/1131
(74 %)
18 diff
(98.5 %id)
BU175946 eye, retinoblastoma .b 289 to 1120 1 to 829       829/843
(98 %)
7 diff
(99.2 %id)
BM697297 eye, lens .b 299 to 812 1 to 514   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 514/514
(100 %)
0 diff
(100 %id)
BG108055 Bone, osteosarcoma, cell line .b 305 to 1120 1 to 816       816/823
(99 %)
19 diff
(97.7 %id)
AA626477 lung, lung carcinoma .b 307 to 1062 1 to 745       745/745
(100 %)
59 diff
(92.1 %id)
CK005859 brain/CNS, Human Brain - Frontal Cortex .b 316 to 990 1 to 673       673/674
(99 %)
6 diff
(99.2 %id)
CK005500 brain/CNS, Human Brain - Frontal Cortex .b 316 to 976 1 to 650       650/656
(99 %)
23 diff
(96.5 %id)
BM907661 large cell carcinoma, lung .b 324 to 1119 823 to 24   AAA Submitted on the opposite strand 800/960
(83 %)
9 diff
(99.1 %id)
TI_154191173   .b 344 to 1119 50 to 823   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 774/774
(100 %)
7 diff
(99.1 %id)
AI654181 Kidney .b 364 to 1116 751 to 1       751/751
(100 %)
7 diff
(99.1 %id)
TI_154019656   .b 368 to 1084 798 to 82       717/798
(89 %)
2 diff
(99.8 %id)
BF675526 Prostate .b 378 to 1047 1 to 670       670/894
(74 %)
38 diff
(95.8 %id)
BE888024 leiomyosarcoma, uterus .b 395 to 1067 1 to 677       677/885
(76 %)
11 diff
(98.8 %id)
BM887715 eye .b 397 to 884 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BF805262 colon_ins .b 401 to 906 6 to 512       507/512
(99 %)
9 diff
(98.3 %id)
AA329507   .b 402 to 748 1 to 347       347/347
(100 %)
0 diff
(100 %id)
TI_154053871   .b 417 to 1120 789 to 85       705/1017
(69 %)
3 diff
(99.8 %id)
TI_154092296   .b 417 to 1112 784 to 88   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 697/909
(76 %)
26 diff
(97.2 %id)
TI_151701607   .b 417 to 1114 783 to 85   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 699/951
(73 %)
4 diff
(99.6 %id)
BI044367 ovary .b 419 to 926 29 to 536       510/536
(95 %)
13 diff
(97.6 %id)
BM693985 eye, Retina Foveal and Macular .b 449 to 848 1 to 399   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 399/399
(100 %)
1 diff
(99.8 %id)
TI_154009217   .b 459 to 1116 773 to 111       663/883
(75 %)
10 diff
(98.9 %id)
AW068535 Bone, Hip .b 466 to 1116 651 to 1       651/651
(100 %)
0 diff
(100 %id)
AI651105 pooled germ cell tumors .b 481 to 1114 634 to 1       634/634
(100 %)
3 diff
(99.6 %id)
BE792801 lung, small cell carcinoma .b 483 to 1119 1 to 634       634/848
(74 %)
6 diff
(99.3 %id)
BQ340975 nervous_normal .b 487 to 916 447 to 18       430/447
(96 %)
0 diff
(100 %id)
BM505527 insulinoma, Pancreas .b 490 to 1119 646 to 16   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 631/634
(99 %)
1 diff
(99.9 %id)
CA434538 lung, Metastatic Chondrosarcoma .b 492 to 1112 640 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 622/622
(100 %)
17 diff
(97.3 %id)
CA438796 lung, Metastatic Chondrosarcoma .b 492 to 1119 645 to 17   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 629/629
(100 %)
5 diff
(99.3 %id)
AI571178 anaplastic oligodendroglioma, brain .b 493 to 1119 626 to 1       626/629
(99 %)
17 diff
(97.3 %id)
AI656902 pooled germ cell tumors .b 493 to 1071 577 to 1       577/584
(98 %)
6 diff
(99.0 %id)
BM310179 insulinoma, Pancreas .b 495 to 1119 640 to 16   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 625/625
(100 %)
2 diff
(99.7 %id)
AI692484 carcinoid, lung .b 558 to 1120 564 to 2       563/564
(99 %)
0 diff
(100 %id)
BQ723593 sympathetic trunk .b 566 to 1120 1 to 554       554/579
(95 %)
1 diff
(99.9 %id)
AI754409 bone marrow stroma .b 573 to 1112 559 to 20   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 540/540
(100 %)
0 diff
(100 %id)
EL951005 eyeball .b 579 to 1080 11 to 511       501/511
(98 %)
6 diff
(98.9 %id)
AA707255   .b 585 to 1118 536 to 1     Submitted on the opposite strand 536/536
(100 %)
12 diff
(97.8 %id)
EL946886 eyeball .b 596 to 935 1 to 342       341/342
(99 %)
11 diff
(96.8 %id)
BQ717027 sympathetic trunk .b 603 to 991 1 to 390       390/1292
(30 %)
8 diff
(99.4 %id)
DB570208 hypothalamus .b 608 to 1118 1 to 511     Submitted on the opposite strand 511/512
(99 %)
1 diff
(99.9 %id)
AA976958 pooled germ cell tumors .b 608 to 1114 507 to 1       507/507
(100 %)
0 diff
(100 %id)
D53792   .b 611 to 957 1 to 344       344/344
(100 %)
4 diff
(98.9 %id)
D55325   .b 611 to 909 1 to 302       302/305
(99 %)
5 diff
(98.4 %id)
BP390864 pancreatic islet .b 618 to 1114 1 to 497     Submitted on the opposite strand 497/497
(100 %)
0 diff
(100 %id)
BP393594 pancreatic islet .b 618 to 1119 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
AA340328 brain .b 619 to 951 9 to 344       336/344
(97 %)
6 diff
(98.3 %id)
DB577678 hypothalamus .b 622 to 1117 1 to 496     Submitted on the opposite strand 496/496
(100 %)
3 diff
(99.4 %id)
EL950598 eyeball .b 629 to 1125 8 to 504   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 497/504
(98 %)
7 diff
(98.7 %id)
BU077447 insulinoma, Pancreas .b 630 to 1114 502 to 18   AAA Submitted on the opposite strand 485/485
(100 %)
0 diff
(100 %id)
C05857   .b 632 to 1120 510 to 8       504/516
(97 %)
3 diff
(99.5 %id)
DB577563 hypothalamus .b 634 to 1117 1 to 484     Submitted on the opposite strand 484/484
(100 %)
1 diff
(99.8 %id)
DB570670 hypothalamus .b 636 to 1119 1 to 483     Submitted on the opposite strand 483/483
(100 %)
2 diff
(99.6 %id)
DB577921 hypothalamus .b 637 to 1110 1 to 474     Submitted on the opposite strand 474/476
(99 %)
2 diff
(99.6 %id)
DB570475 hypothalamus .b 638 to 1114 1 to 477     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
AW405768 lymph .b 638 to 969 7 to 338       332/338
(98 %)
13 diff
(96.2 %id)
BE222382 carcinoid, lung .b 638 to 1114 477 to 1       477/477
(100 %)
0 diff
(100 %id)
DB572383 hypothalamus .b 639 to 1119 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AW901313 nervous_normal .b 650 to 816 167 to 1       167/167
(100 %)
0 diff
(100 %id)
DB566849 hypothalamus .b 651 to 1112 1 to 462     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
DB577025 hypothalamus .b 651 to 1118 1 to 468     Submitted on the opposite strand 468/469
(99 %)
4 diff
(99.2 %id)
AA057836 cornea .b 651 to 1112 462 to 1       462/462
(100 %)
0 diff
(100 %id)
DB543657 hippocampus .b 653 to 1119 1 to 467     Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
DB567450 hypothalamus .b 653 to 1114 1 to 462     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
DB567373 hypothalamus .b 654 to 1114 1 to 461     Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
AI391730 anaplastic oligodendroglioma, brain .b 654 to 1123 470 to 1       470/470
(100 %)
0 diff
(100 %id)
DB573911 hypothalamus .b 656 to 1112 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
AA608554 lung, lung carcinoma .b 661 to 1105 445 to 1       445/445
(100 %)
0 diff
(100 %id)
DB572883 hypothalamus .b 667 to 1117 1 to 451     Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
DB549449 hippocampus .b 675 to 1119 1 to 445     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
AW245286 lung, small cell carcinoma .b 759 to 1112 364 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 354/354
(100 %)
0 diff
(100 %id)
BM667940 eye, lens .b 782 to 1114 349 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 333/333
(100 %)
0 diff
(100 %id)
BM663982 eye, Retina Foveal and Macular .b 818 to 1112 313 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 295/295
(100 %)
0 diff
(100 %id)
N91851 lung .b 984 to 1120 142 to 6       137/142
(96 %)
0 diff
(100 %id)
DB484142 hypothalamus .c 1 to 447 1 to 447   tiling clone,   447/447
(100 %)
0 diff
(100 %id)
BG751712 eye, normal pigmented retinal epithelium .c 239 to 1024 1 to 787 L240T C241W tiling clone,   787/787
(100 %)
5 diff
(99.4 %id)
BG753289 eye, normal pigmented retinal epithelium .c 239 to 1146 1 to 928 E109R D110G G111W S112I V113S ...     928/973
(95 %)
38 diff
(96.1 %id)
BM707593 eye, RPE and Choroid .c 273 to 853 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AA365812 pineal body .c 880 to 1205 1 to 330       330/330
(100 %)
8 diff
(97.6 %id)
CN287266 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 883 to 1322 1 to 440   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 440/440
(100 %)
5 diff
(98.9 %id)
AA303274 aorta .c 884 to 1195 10 to 323       314/323
(97 %)
6 diff
(98.2 %id)
AA707279   .c 884 to 1325 442 to 1     Submitted on the opposite strand 442/444
(99 %)
1 diff
(99.8 %id)
DB553102 hypothalamus .c 886 to 1327 1 to 441     Submitted on the opposite strand 441/441
(100 %)
4 diff
(99.1 %id)
DB574574 hypothalamus .c 886 to 1325 1 to 440     Submitted on the opposite strand 440/442
(99 %)
1 diff
(99.8 %id)
D55909   .c 888 to 1150 1 to 262       262/262
(100 %)
5 diff
(98.1 %id)
BU733156 eye, RPE and Choroid .c 894 to 1324 447 to 17       431/447
(96 %)
0 diff
(100 %id)
DB547459 hippocampus .c 895 to 1324 1 to 430     Submitted on the opposite strand 430/435
(98 %)
1 diff
(99.8 %id)
DB562390 hypothalamus .c 905 to 1325 1 to 421     Submitted on the opposite strand 421/421
(100 %)
4 diff
(99.1 %id)
AI270278 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 906 to 1322 427 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AA100016   .c 907 to 1309 404 to 1     Submitted on the opposite strand 404/404
(100 %)
1 diff
(99.8 %id)
W26607 eye, retina .c 907 to 1203 316 to 21       296/347
(85 %)
0 diff
(100 %id)
DB555254 hypothalamus .c 908 to 1322 1 to 416     Submitted on the opposite strand 416/416
(100 %)
5 diff
(98.8 %id)
DB562387 hypothalamus .c 912 to 1327 1 to 415     Submitted on the opposite strand 415/415
(100 %)
9 diff
(97.9 %id)
AW960234   .c 915 to 1327 1 to 413   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
AI202997 pooled germ cell tumors .c 925 to 1401 482 to 1   tiling clone,   482/499
(96 %)
34 diff
(93.2 %id)
AA824435 germinal center B cell .c 928 to 1320 445 to 53   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
DB530470 hippocampus .c 948 to 1331 1 to 384   tiling clone, Submitted on the opposite strand 384/384
(100 %)
0 diff
(100 %id)
EB361574 eye, lens .c 959 to 1303 345 to 1       345/345
(100 %)
7 diff
(98.0 %id)
T07227   .c 981 to 1310 330 to 1       330/332
(99 %)
1 diff
(99.7 %id)
EB361961 eye, lens .c 988 to 1322 336 to 1       336/336
(100 %)
4 diff
(98.9 %id)
D55570   .c 1024 to 1322 299 to 1     Submitted on the opposite strand 299/299
(100 %)
2 diff
(99.4 %id)
BY795572 eye .c 1032 to 1328 1 to 297       297/297
(100 %)
6 diff
(98.0 %id)
W27137 eye, retina .c 1034 to 1318 294 to 10       285/341
(83 %)
0 diff
(100 %id)
DB561381 hypothalamus .c 1037 to 1461 1 to 426   tiling clone, Submitted on the opposite strand 426/429
(99 %)
4 diff
(99.1 %id)
AA164260   .c 1037 to 1306 270 to 1       270/278
(97 %)
5 diff
(98.3 %id)
BX393817 Neuroblastoma Cot 25-normalized .c 1038 to 1324 1 to 287       287/287
(100 %)
3 diff
(99.0 %id)
BX375770 Neuroblastoma Cot 25-normalized .c 1043 to 1325 283 to 1     Submitted on the opposite strand 283/294
(96 %)
5 diff
(98.3 %id)
T06679   .c 1092 to 1327 409 to 171   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 239/409
(58 %)
0 diff
(100 %id)
CB119661 Liver .c 1102 to 1312 211 to 1     Submitted on the opposite strand 211/211
(100 %)
9 diff
(95.8 %id)
AA083917   .c 1131 to 1321 193 to 1     Submitted on the opposite strand 193/193
(100 %)
2 diff
(99.0 %id)
AI950142 anaplastic oligodendroglioma, brain .c 1143 to 1273 131 to 1       131/131
(100 %)
4 diff
(97.0 %id)
AI174484   .c 1146 to 1323 178 to 1       178/178
(100 %)
0 diff
(100 %id)
AW020604 cochlea, ear .c 1180 to 1328 1 to 149       149/177
(84 %)
6 diff
(96.7 %id)
BU589076 mixed (pool of 40 RNAs) .c 1181 to 1327 1 to 147   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 147/147
(100 %)
1 diff
(99.4 %id)
AA324670 brain, cerebellum .d 1 to 354 1 to 354       354/366
(96 %)
2 diff
(99.5 %id)
BU527034 epidermoid carcinoma, cell line, lung .d 1 to 878 1 to 892 exact tiling clone,   892/937
(95 %)
27 diff
(97.2 %id)
NM_004181.4   .e 1 to 1123 1 to 1123 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1123/1123
(100 %)
0 diff
(100 %id)
BP308208 brain .e 1 to 587 1 to 587   tiling clone,   587/587
(100 %)
0 diff
(100 %id)
BG253060 adenocarcinoma, cell line, Liver .e 17 to 828 1 to 805 M179N P180A P182S V183G N184E ...     805/861
(93 %)
17 diff
(98.1 %id)
AW239471 lung, cell line .e 21 to 626 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BC000332 Lung, small cell carcinoma .e 32 to 1123 1 to 1092 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1092/1092
(100 %)
0 diff
(100 %id)
BC018838.
matches multiple genes
adenocarcinoma cell line, colon, Colon, adenocarcinoma .e 32 to 1123 1 to 1092   available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base), also hits gene PPIL3andCLK1 1092/1092
(100 %)
0 diff
(100 %id)
AU107465   .e 48 to 97 1 to 50       50/50
(100 %)
0 diff
(100 %id)
DT215222 brain .e 48 to 622 1 to 575       575/576
(99 %)
0 diff
(100 %id)
AI815397.
matches multiple genes
brain, frontal lobe .e 48 to 479 1 to 432     also hits gene ZNF529 432/432
(100 %)
0 diff
(100 %id)
TI_45210411   .e 48 to 995 91 to 1055 M179N P180A P182S V183R N184*     965/1057
(91 %)
57 diff
(94.7 %id)
TI_44342899   .e 48 to 888 133 to 970 K199X     838/1019
(82 %)
24 diff
(97.7 %id)
TI_44346523   .e 48 to 993 87 to 1024 Q58S H59M E60R N61T F62S ...     938/1026
(91 %)
52 diff
(95.0 %id)
CB107665 Liver .e 48 to 553 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CB111072 Liver .e 48 to 564 1 to 517       517/517
(100 %)
0 diff
(100 %id)
TI_154092276   .e 49 to 888 66 to 890 S18Y   Submitted on the opposite strand 825/958
(86 %)
23 diff
(97.6 %id)
DB478790 hippocampus .e 51 to 532 1 to 482       482/482
(100 %)
0 diff
(100 %id)
DB486267 hypothalamus .e 51 to 475 1 to 425       425/425
(100 %)
0 diff
(100 %id)
DB496347 hypothalamus .e 51 to 521 1 to 471       471/471
(100 %)
0 diff
(100 %id)
DB496428 hypothalamus .e 51 to 545 1 to 495       495/495
(100 %)
0 diff
(100 %id)
DB499104 hypothalamus .e 51 to 538 1 to 488       488/488
(100 %)
0 diff
(100 %id)
DB499348 hypothalamus .e 51 to 531 1 to 481       481/481
(100 %)
0 diff
(100 %id)
DB499541 hypothalamus .e 51 to 534 1 to 484       484/484
(100 %)
0 diff
(100 %id)
DB501115 hypothalamus .e 51 to 543 1 to 493       493/493
(100 %)
0 diff
(100 %id)
DB505737 hypothalamus .e 51 to 547 1 to 497       497/497
(100 %)
0 diff
(100 %id)
DB506646 hypothalamus .e 51 to 529 1 to 479       479/479
(100 %)
0 diff
(100 %id)
AK315368 cerebellum .e 52 to 768 1 to 717 S18Y F181S     717/717
(100 %)
2 diff
(99.8 %id)
DT215994 brain .e 52 to 754 1 to 703       703/703
(100 %)
0 diff
(100 %id)
DT218525 brain .e 52 to 604 1 to 553       553/553
(100 %)
0 diff
(100 %id)
DB501195 hypothalamus .e 52 to 538 1 to 487       487/487
(100 %)
0 diff
(100 %id)
CB106617 Liver .e 52 to 464 1 to 413       413/413
(100 %)
0 diff
(100 %id)
CB108046 Liver .e 52 to 454 1 to 403       403/403
(100 %)
0 diff
(100 %id)
DA526314 brain .e 53 to 620 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
TI_57216861   .e 53 to 1034 30 to 1019 M6S E7G I8D N9Q E11R ...     990/1067
(92 %)
38 diff
(96.5 %id)
BQ942583 large cell carcinoma, lung .e 60 to 866 1 to 817 Q209P G210R S215L A216C V217R ...     817/866
(94 %)
21 diff
(97.6 %id)
BC006305 Muscle, rhabdomyosarcoma .e 61 to 1118 1 to 1058 exact available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1058/1058
(100 %)
0 diff
(100 %id)
CN287254 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 61 to 702 1 to 642       642/642
(100 %)
0 diff
(100 %id)
CF130838 Chondrosarcoma Lung Metastasis cell lines, lung .e 61 to 796 1 to 736 exact     736/736
(100 %)
0 diff
(100 %id)
TI_154192974   .e 61 to 1006 51 to 988 exact     938/1019
(92 %)
29 diff
(97.2 %id)
TI_154193333   .e 61 to 1039 51 to 1006 S18Y K199X Q209H AAA   956/1019
(93 %)
32 diff
(96.9 %id)
AW160566 brain, frontal lobe .e 63 to 586 1 to 524   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 524/524
(100 %)
1 diff
(99.9 %id)
BU151343 brain, neuroblastoma, cell line .e 63 to 948 1 to 888 exact     888/888
(100 %)
2 diff
(99.8 %id)
BQ943913 large cell carcinoma, lung .e 63 to 945 1 to 886 exact     886/886
(100 %)
4 diff
(99.6 %id)
BQ891569 carcinoma, cell line, Prostate .e 63 to 869 1 to 811 K221R A222Q A223P     811/843
(96 %)
11 diff
(98.7 %id)
BQ954552 large cell carcinoma, lung .e 63 to 955 1 to 898 exact     898/898
(100 %)
14 diff
(98.5 %id)
CF127679 Chondrosarcoma Lung Metastasis cell lines, lung .e 64 to 795 1 to 732 exact     732/732
(100 %)
0 diff
(100 %id)
TI_154193242   .e 64 to 936 51 to 919 exact     869/869
(100 %)
7 diff
(99.2 %id)
BG519593 brain, neuroblastoma .e 65 to 948 1 to 892 S18Y     892/895
(99 %)
19 diff
(97.9 %id)
BU164382 large cell carcinoma, lung .e 65 to 846 1 to 792 S215L A216C V217R A218G L219S ...     792/910
(87 %)
15 diff
(98.4 %id)
BQ437724 eye, retinoblastoma .e 65 to 938 1 to 879 exact     879/893
(98 %)
12 diff
(98.7 %id)
BM511194 insulinoma, Pancreas .e 67 to 586 8 to 527   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 520/527
(98 %)
7 diff
(98.7 %id)
BU193272 eye, retinoblastoma .e 67 to 846 1 to 791 K195X E208X Q209P G210R E211R ...     791/836
(94 %)
19 diff
(97.8 %id)
BQ719181 sympathetic trunk .e 67 to 939 1 to 883 Q209A     883/885
(99 %)
19 diff
(97.9 %id)
CA941639 Pancreas, Purified pancreatic islet .e 67 to 712 1 to 646   fully sequenced,   646/646
(100 %)
3 diff
(99.6 %id)
BG750363 eye, normal pigmented retinal epithelium .e 69 to 968 1 to 911 K65R I67M E69R L70A K71E ...     911/911
(100 %)
27 diff
(97.1 %id)
BG751741 eye, normal pigmented retinal epithelium .e 69 to 818 1 to 750 exact     750/750
(100 %)
0 diff
(100 %id)
TI_59379855   .e 69 to 997 100 to 1040 I93N G94R L95T I96Y H97S ...     941/949
(99 %)
59 diff
(93.8 %id)
TI_154189325   .e 69 to 1085 50 to 1065 exact     1016/1049
(96 %)
19 diff
(98.2 %id)
TI_154189409   .e 69 to 890 50 to 863 R27S H59D K65E D104N G107R ...     814/1014
(80 %)
31 diff
(97.0 %id)
TI_154189558   .e 69 to 913 50 to 891 K221X     842/1025
(82 %)
6 diff
(99.5 %id)
TI_154192921   .e 69 to 1085 51 to 1057 exact AAA   1007/1032
(97 %)
16 diff
(98.5 %id)
TI_154192970   .e 69 to 1111 50 to 1085 S18Y K221X     1036/1038
(99 %)
24 diff
(97.7 %id)
BM460521 leiomyosarcoma, uterus .e 70 to 804 1 to 743 V200A C201R R202Q E203R F204I ...     743/1049
(70 %)
29 diff
(97.3 %id)
BQ422542 large cell carcinoma, lung .e 70 to 974 5 to 907 G210R     903/907
(99 %)
20 diff
(97.8 %id)
CB177351 Pancreas, Purified pancreatic islet .e 70 to 712 4 to 646   fully sequenced,   643/646
(99 %)
6 diff
(99.1 %id)
BU542740 carcinoma, cell line, Prostate .e 70 to 833 1 to 766 A223S     766/899
(85 %)
6 diff
(99.4 %id)
CF127418 Chondrosarcoma Lung Metastasis cell lines, lung .e 70 to 856 1 to 786 exact     786/786
(100 %)
1 diff
(99.9 %id)
CF126475 Chondrosarcoma Lung Metastasis cell lines, lung .e 70 to 794 1 to 725 K221X     725/725
(100 %)
0 diff
(100 %id)
CF126351 Chondrosarcoma Lung Metastasis cell lines, lung .e 70 to 795 1 to 726 exact     726/726
(100 %)
0 diff
(100 %id)
CN287241 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 71 to 810 1 to 740 exact     740/740
(100 %)
0 diff
(100 %id)
BU501230 eye, normal pigmented retinal epithelium .e 71 to 932 1 to 864 exact     864/906
(95 %)
5 diff
(99.5 %id)
BQ953837 brain, neuroblastoma, cell line .e 71 to 968 1 to 905 C220W K221Q     905/925
(97 %)
24 diff
(97.5 %id)
BQ924568 brain, neuroblastoma, cell line .e 71 to 955 1 to 891 exact     891/924
(96 %)
15 diff
(98.4 %id)
BU152639 carcinoma, cell line, Prostate .e 71 to 928 1 to 859 exact     859/862
(99 %)
6 diff
(99.4 %id)
BQ925200 large cell carcinoma, lung .e 71 to 981 1 to 914 exact     914/922
(99 %)
10 diff
(99.0 %id)
CX752971 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 71 to 807 1 to 737 exact   Submitted on the opposite strand 737/737
(100 %)
0 diff
(100 %id)
BQ051339 large cell carcinoma, lung .e 72 to 901 1 to 847 L193P L194A K195E D196G A197R ...     847/1050
(80 %)
32 diff
(97.0 %id)
BU164929 eye, retinoblastoma .e 72 to 929 1 to 869 Q209A G210R E211R V212S R213P ...     869/881
(98 %)
17 diff
(98.1 %id)
BC005117 Lung, small cell carcinoma .e 73 to 1123 1 to 1051 exact available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1051/1051
(100 %)
0 diff
(100 %id)
CN287230 embryonic stem cells, DMSO-treated H9 cellline .e 73 to 833 1 to 761 exact     761/761
(100 %)
0 diff
(100 %id)
CN287235 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 73 to 858 1 to 785 exact     785/785
(100 %)
2 diff
(99.8 %id)
BM465073 lymph, lymphoma, cell line .e 73 to 969 30 to 924 K195X F204S T205P E206S R207V ...     895/1096
(81 %)
34 diff
(96.9 %id)
BU190008 eye, retinoblastoma .e 73 to 955 1 to 883 exact     883/895
(98 %)
11 diff
(98.8 %id)
CF127837 Chondrosarcoma Lung Metastasis cell lines, lung .e 73 to 830 1 to 753 exact     753/806
(93 %)
10 diff
(98.8 %id)
TI_154193522   .e 73 to 830 51 to 803 exact AAA   753/969
(77 %)
10 diff
(99.0 %id)
AV706865 adrenal gland .e 74 to 462 1 to 389       389/389
(100 %)
0 diff
(100 %id)
CN287257 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 74 to 810 9 to 745 exact     737/745
(98 %)
0 diff
(100 %id)
BQ267597 insulinoma, Pancreas .e 74 to 586 8 to 520   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 513/520
(98 %)
6 diff
(98.9 %id)
BQ430337 large cell carcinoma, lung .e 74 to 997 1 to 931 V200A V217G     931/1120
(83 %)
33 diff
(97.1 %id)
BQ549957 insulinoma, Pancreas .e 74 to 586 8 to 520   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 513/520
(98 %)
6 diff
(98.9 %id)
BQ422567 large cell carcinoma, lung .e 74 to 942 1 to 879 exact     879/929
(94 %)
20 diff
(97.9 %id)
BQ720813 sympathetic trunk .e 74 to 955 1 to 880 exact     880/919
(95 %)
7 diff
(99.3 %id)
CX761539 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 75 to 805 1 to 731 exact   Submitted on the opposite strand 731/731
(100 %)
0 diff
(100 %id)
CX753169 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 76 to 830 1 to 754 C220X K221Q   Submitted on the opposite strand 754/758
(99 %)
9 diff
(98.9 %id)
TI_154193081   .e 76 to 1060 51 to 1023 S18Y K221X AAA   973/1022
(95 %)
23 diff
(97.8 %id)
TI_154194185   .e 76 to 930 51 to 896 L193C L194*     846/1043
(81 %)
21 diff
(98.0 %id)
BM474803 duodenal adenocarcinoma, cell line, small intestine .e 77 to 852 1 to 776 Q209P K221R A222Q A223P     776/1025
(75 %)
8 diff
(99.3 %id)
BF965856 Bone, osteosarcoma, cell line .e 78 to 910 1 to 833 K195E D196G A197R A198C K199Q ...     831/877
(94 %)
41 diff
(95.4 %id)
BM876379 insulinoma, Pancreas .e 78 to 586 1 to 509   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 509/509
(100 %)
4 diff
(99.3 %id)
BQ231097 large cell carcinoma, lung .e 78 to 925 1 to 852 G210R     852/1039
(82 %)
11 diff
(99.0 %id)
BU175254 large cell carcinoma, lung .e 78 to 960 1 to 888 exact     888/891
(99 %)
10 diff
(98.9 %id)
BQ581977 insulinoma, Pancreas .e 78 to 586 1 to 509   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 509/509
(100 %)
4 diff
(99.3 %id)
BQ718683 sympathetic trunk .e 78 to 971 1 to 905 exact     905/945
(95 %)
22 diff
(97.7 %id)
BM686593 eye, optic nerve .e 78 to 710 9 to 642     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 634/645
(98 %)
9 diff
(98.7 %id)
BU070071 insulinoma, Pancreas .e 79 to 586 7 to 514   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 508/514
(98 %)
6 diff
(98.9 %id)
BU789379 insulinoma, Pancreas .e 79 to 505 1 to 427   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 427/427
(100 %)
4 diff
(99.1 %id)
BE297061 muscle, rhabdomyosarcoma .e 80 to 672 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BE791494 lung, small cell carcinoma .e 80 to 668 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BE796927 lung, small cell carcinoma .e 80 to 892 1 to 807 K199R V200S C201A R202E E203N ...     807/920
(87 %)
16 diff
(98.3 %id)
CA777123 Pancreas, Purified pancreatic islet .e 81 to 712 1 to 632   fully sequenced,   632/632
(100 %)
2 diff
(99.7 %id)
TI_154193234   .e 82 to 972 50 to 939 F204S T205P E206S R207V E208S ...     890/893
(99 %)
5 diff
(99.5 %id)
CF127672 Chondrosarcoma Lung Metastasis cell lines, lung .e 83 to 888 1 to 805 F204S T205P E206S R207V E208S ...     805/805
(100 %)
1 diff
(99.9 %id)
BQ719819 sympathetic trunk .e 84 to 993 1 to 914 exact     914/914
(100 %)
13 diff
(98.6 %id)
BQ892388 sympathetic trunk .e 84 to 980 1 to 901 V217R A218G L219S C220L K221Q ...     901/908
(99 %)
18 diff
(98.1 %id)
BE781115 eye, retinoblastoma .e 85 to 806 1 to 724 K199R V200S C201A R202E E203N ...     724/1035
(69 %)
11 diff
(99.0 %id)
BM564828 eye, retinoblastoma .e 85 to 1061 1 to 993 exact     993/1013
(98 %)
40 diff
(96.1 %id)
BE254151 eye, retinoblastoma .e 88 to 560 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BE378417 endometrium, adenocarcinoma cell line, uterus .e 88 to 751 1 to 660       660/722
(91 %)
7 diff
(99.1 %id)
BE792930 lung, small cell carcinoma .e 88 to 900 1 to 808 K199R V200S C201A R202E E203N ...     808/965
(83 %)
13 diff
(98.7 %id)
BE394304 endometrium, adenocarcinoma cell line, uterus .e 89 to 757 1 to 668       668/753
(88 %)
7 diff
(99.1 %id)
CN287248 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 90 to 543 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BM464768 lymph, lymphoma, cell line .e 90 to 870 1 to 786 exact     786/988
(79 %)
6 diff
(99.4 %id)
BG749169 eye, normal pigmented retinal epithelium .e 91 to 998 1 to 914 exact AAA   914/1005
(90 %)
18 diff
(98.3 %id)
BU175151 large cell carcinoma, lung .e 91 to 929 1 to 844 C220L K221Q     844/900
(93 %)
16 diff
(98.3 %id)
BQ716761 sympathetic trunk .e 91 to 1070 1 to 977 exact     977/979
(99 %)
13 diff
(98.7 %id)
BQ723369 sympathetic trunk .e 91 to 871 1 to 794 Q209A G210R E211R V212S R213P ...     794/898
(88 %)
15 diff
(98.4 %id)
BQ926463 large cell carcinoma, lung .e 92 to 995 1 to 907 exact     907/911
(99 %)
6 diff
(99.4 %id)
BU950999 Pancreas, Purified pancreatic islet .e 95 to 712 1 to 618   fully sequenced,   618/618
(100 %)
1 diff
(99.9 %id)
CV026037 mixed .e 97 to 668 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BE791427 lung, small cell carcinoma .e 98 to 783 1 to 686       686/686
(100 %)
0 diff
(100 %id)
CF126085 Chondrosarcoma Lung Metastasis cell lines, lung .e 99 to 901 1 to 803       803/805
(99 %)
2 diff
(99.8 %id)
TI_154188920   .e 99 to 972 51 to 917       867/1017
(85 %)
11 diff
(99.0 %id)
X04741   .e 99 to 1084 1 to 985       985/1014
(97 %)
12 diff
(98.9 %id)
CB115857 Liver .e 101 to 662 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CB118363 Liver .e 101 to 659 1 to 559       559/559
(100 %)
0 diff
(100 %id)
ES314777 occipital scalp hair, skin .e 103 to 237 1 to 135       135/135
(100 %)
0 diff
(100 %id)
BQ934585 large cell carcinoma, lung .e 105 to 955 1 to 866       866/870
(99 %)
28 diff
(96.8 %id)
CN287231 embryonic stem cells, DMSO-treated H9 cellline .e 109 to 848 1 to 740       740/740
(100 %)
0 diff
(100 %id)
BQ717962 sympathetic trunk .e 110 to 964 1 to 864       864/874
(98 %)
24 diff
(97.3 %id)
CA776679 Pancreas, Purified pancreatic islet .e 110 to 712 1 to 603   fully sequenced,   603/603
(100 %)
1 diff
(99.9 %id)
CB115162 Liver .e 110 to 662 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CB115521 Liver .e 110 to 662 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CN287250 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 122 to 639 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BQ927129 large cell carcinoma, lung .e 122 to 1024 1 to 912       912/913
(99 %)
26 diff
(97.2 %id)
BU502761 carcinoma, cell line, Prostate .e 122 to 995 1 to 884       884/937
(94 %)
15 diff
(98.4 %id)
CN287252 embryonic stem cells, DMSO-treated H9 cellline .e 124 to 502 1 to 379       379/379
(100 %)
0 diff
(100 %id)
BE796108 lung, small cell carcinoma .e 124 to 917 1 to 802       802/904
(88 %)
25 diff
(97.3 %id)
BM472773 duodenal adenocarcinoma, cell line, small intestine .e 125 to 1061 1 to 948       948/989
(95 %)
29 diff
(97.1 %id)
CF126055 Chondrosarcoma Lung Metastasis cell lines, lung .e 126 to 794 1 to 669       669/669
(100 %)
0 diff
(100 %id)
TI_154188983   .e 126 to 1113 51 to 1040   AAA   990/996
(99 %)
27 diff
(97.3 %id)
CN287244 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 128 to 854 6 to 732       727/732
(99 %)
2 diff
(99.8 %id)
CF126590 Chondrosarcoma Lung Metastasis cell lines, lung .e 138 to 796 1 to 659       659/659
(100 %)
4 diff
(99.4 %id)
TI_154189602   .e 138 to 1055 51 to 956       906/1015
(89 %)
22 diff
(97.9 %id)
BE798847 lung, small cell carcinoma .e 140 to 990 21 to 859       839/1025
(81 %)
24 diff
(97.7 %id)
CD618117   .e 142 to 842 716 to 17       700/740
(94 %)
3 diff
(99.6 %id)
CD618119   .e 142 to 842 708 to 14       695/738
(94 %)
11 diff
(98.6 %id)
CR614115 fetal brain .e 142 to 1104 1 to 963       963/963
(100 %)
0 diff
(100 %id)
BQ631081 insulinoma, Pancreas .e 142 to 538 23 to 419   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 397/419
(94 %)
0 diff
(100 %id)
TI_154189572   .e 142 to 1084 83 to 1012       930/1081
(86 %)
32 diff
(97.1 %id)
CN287224 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 143 to 833 1 to 693       693/693
(100 %)
5 diff
(99.3 %id)
CN287234 embryonic stem cells, DMSO-treated H9 cellline .e 144 to 816 1 to 673       673/673
(100 %)
0 diff
(100 %id)
BE262890 brain, neuroblastoma .e 147 to 845 35 to 727       693/821
(84 %)
18 diff
(97.9 %id)
BM690677 eye, Retina Foveal and Macular .e 150 to 722 8 to 578       571/578
(98 %)
9 diff
(98.5 %id)
BF038612 adenocarcinoma, ovary .e 161 to 880 1 to 727       727/865
(84 %)
34 diff
(96.1 %id)
BG436725 large cell carcinoma, lung .e 165 to 843 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
CN287265 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 183 to 663 1 to 481       481/481
(100 %)
0 diff
(100 %id)
BQ021061 lung, Metastatic Chondrosarcoma .e 185 to 833 665 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 648/648
(100 %)
2 diff
(99.7 %id)
BQ422136 large cell carcinoma, lung .e 198 to 1038 1 to 843       843/845
(99 %)
6 diff
(99.3 %id)
TI_154092262   .e 205 to 1118 997 to 87   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 911/934
(97 %)
20 diff
(97.9 %id)
CN287251 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 211 to 793 9 to 592       584/592
(98 %)
7 diff
(98.9 %id)
BE792638 lung, small cell carcinoma .e 211 to 1053 1 to 837       837/838
(99 %)
13 diff
(98.5 %id)
BM508943 insulinoma, Pancreas .e 216 to 765 1 to 550       550/550
(100 %)
9 diff
(98.4 %id)
TI_1948100850   .e 219 to 767 679 to 129       551/1336
(41 %)
13 diff
(99.1 %id)
BU556998 ovary, teratocarcinoma, cell line .e 222 to 1123 923 to 16   AAA Submitted on the opposite strand 908/908
(100 %)
14 diff
(98.5 %id)
N39963 melanocyte .e 242 to 457 1 to 216       216/216
(100 %)
0 diff
(100 %id)
BF036499 adenocarcinoma, ovary .e 354 to 612 1 to 259       259/259
(100 %)
0 diff
(100 %id)
AI675847 Prostate .e 446 to 1119 672 to 1       672/672
(100 %)
3 diff
(99.6 %id)
BQ223520 large cell carcinoma, lung .e 450 to 1007 377 to 936       560/566
(98 %)
13 diff
(97.8 %id)
AI360681 pooled germ cell tumors .e 452 to 891 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
ES311370 frontal balding hair, skin .e 478 to 638 1 to 161       161/161
(100 %)
0 diff
(100 %id)
BQ613837 insulinoma, Pancreas .e 482 to 1123 657 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 642/642
(100 %)
0 diff
(100 %id)
AW901426 nervous_normal .e 498 to 820 1 to 319       319/319
(100 %)
15 diff
(95.3 %id)
BU789117 insulinoma, Pancreas .e 502 to 1123 641 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
BQ575366 Chondrosarcoma Grade II, Left Pelvis .e 508 to 1121 632 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 614/614
(100 %)
1 diff
(99.9 %id)
AW162422 brain, frontal lobe .e 525 to 1118 605 to 11   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 595/595
(100 %)
0 diff
(100 %id)
BM510937 insulinoma, Pancreas .e 525 to 1118 610 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 594/594
(100 %)
0 diff
(100 %id)
BQ272172 insulinoma, Pancreas .e 525 to 1123 614 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 599/599
(100 %)
0 diff
(100 %id)
BQ614104 insulinoma, Pancreas .e 525 to 1123 614 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 599/599
(100 %)
0 diff
(100 %id)
BQ581648 insulinoma, Pancreas .e 525 to 1118 617 to 24   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 594/594
(100 %)
1 diff
(99.9 %id)
BU069838 insulinoma, Pancreas .e 525 to 1123 616 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 599/599
(100 %)
0 diff
(100 %id)
BQ548832 insulinoma, Pancreas .e 526 to 1123 620 to 23   AAA Submitted on the opposite strand 598/598
(100 %)
0 diff
(100 %id)
CD105650 brain, Pituitary .e 530 to 1118 1 to 589   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 589/589
(100 %)
0 diff
(100 %id)
CN287243 embryonic stem cells, DMSO-treated H9 cellline .e 532 to 1122 1 to 591       591/591
(100 %)
0 diff
(100 %id)
CA841828 Pancreas, Purified pancreatic islet .e 538 to 1123 602 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 588/590
(99 %)
17 diff
(97.2 %id)
BM876125 insulinoma, Pancreas .e 542 to 1118 600 to 24   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 577/577
(100 %)
1 diff
(99.9 %id)
BQ614562 insulinoma, Pancreas .e 555 to 1123 591 to 23   AAA Submitted on the opposite strand 569/577
(98 %)
0 diff
(100 %id)
BU952447 Pancreas, Purified pancreatic islet .e 651 to 1122 472 to 1   fully sequenced,   472/472
(100 %)
0 diff
(100 %id)
CA776839 Pancreas, Purified pancreatic islet .e 651 to 1122 472 to 1   fully sequenced,   472/472
(100 %)
0 diff
(100 %id)
CB068440 Pancreas, Purified pancreatic islet .e 651 to 1123 473 to 1   fully sequenced,   473/473
(100 %)
0 diff
(100 %id)
CA941350 Pancreas, Purified pancreatic islet .e 651 to 1123 473 to 1   fully sequenced,   473/473
(100 %)
0 diff
(100 %id)
CA776448 Pancreas, Purified pancreatic islet .e 667 to 1117 451 to 1   fully sequenced,   451/451
(100 %)
0 diff
(100 %id)
N26847 melanocyte .e 711 to 1123 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
BU727969 eye, optic nerve .e 755 to 1129 393 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
CB145865 Liver .f 1 to 450 8 to 456   tiling clone,   456/456
(100 %)
10 diff
(97.9 %id)
CD643937 Embryonic Stem cells .f 1 to 807 5 to 803 C216X K217Q tiling clone,   803/814
(98 %)
22 diff
(97.3 %id)
BG436993 large cell carcinoma, lung .f 8 to 810 1 to 802 Q21S W22G R23A F24S V25W ... tiling clone,   804/802
(100 %)
26 diff
(96.8 %id)
BM083671 large cell carcinoma, lung .f 8 to 736 1 to 724 A218Q A219P tiling clone,   724/724
(100 %)
11 diff
(98.5 %id)
BU167693 eye, retinoblastoma .f 12 to 874 1 to 868 E204X Q205X G206R E207R V208S ... tiling clone,   868/887
(97 %)
14 diff
(98.5 %id)
BE789050 large cell carcinoma, lung .f 30 to 753 1 to 737       735/1154
(63 %)
45 diff
(96.2 %id)
TI_154018368   .f 44 to 673 158 to 796     Submitted on the opposite strand 637/833
(76 %)
21 diff
(97.5 %id)
CN287262 embryonic stem cells, cell lines H1, H7, andH9 .g 1 to 750 12 to 762 exact tiling clone,   753/762
(98 %)
7 diff
(99.1 %id)
F06334 brain, total brain .g 7 to 327 1 to 320       320/320
(100 %)
3 diff
(99.1 %id)
F07477 brain, total brain .g 9 to 327 1 to 319       319/319
(100 %)
2 diff
(99.4 %id)
F08257 brain, total brain .g 9 to 229 1 to 220       220/220
(100 %)
1 diff
(99.6 %id)
F04484 brain, total brain .g 768 to 1025 258 to 1   tiling clone,   258/258
(100 %)
0 diff
(100 %id)
F03705 brain, total brain .g 815 to 1025 211 to 1       211/211
(100 %)
0 diff
(100 %id)
F02629 brain, total brain .g 841 to 1029 191 to 3   tiling clone,   189/191
(98 %)
0 diff
(100 %id)
BG109257 Bone, osteosarcoma, cell line .h 1 to 793 1 to 782 K183R V184L tiling clone,   782/851
(91 %)
18 diff
(97.9 %id)
BI601255 brain, hypothalamus .i 1 to 654 9 to 698 F2Y F4V R6* tiling clone,   646/698
(92 %)
34 diff
(95.2 %id)
AA204658   .i 44 to 427 1 to 390   tiling clone,   384/390
(98 %)
10 diff
(97.5 %id)
TI_45211284   .i 87 to 654 192 to 777   tiling clone,   584/777
(75 %)
25 diff
(96.8 %id)
DB570932 hypothalamus .i 473 to 935 1 to 463   tiling clone, Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
AA207104   .i 542 to 943 404 to 1   tiling clone,   404/404
(100 %)
4 diff
(99.1 %id)
BF946708 nervous_normal .j-u 1058 to 1268 1 to 214   tiling clone,   214/214
(100 %)
16 diff
(92.6 %id)
AA375667 lung .j-u 1545 to 1857 1 to 313   tiling clone,   313/313
(100 %)
0 diff
(100 %id)
DA511202 brain .j-u 4025 to 4583 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
BG028725 Bone, osteosarcoma, cell line .j-u 4968 to 5620 1 to 653   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 653/653
(100 %)
7 diff
(99.0 %id)
DB354681 whole embryo, mainly head .j-u 5055 to 5621 567 to 1   tiling clone,   567/567
(100 %)
6 diff
(99.0 %id)
DN949382.
matches multiple genes
insulinoma, Pancreas .j-u 5272 to 5423 1 to 152   fully sequenced, also hits gene PDPR 152/152
(100 %)
1 diff
(99.4 %id)
DN949524.
matches multiple genes
insulinoma, Pancreas .j-u 5393 to 5635 247 to 1   fully sequenced, also hits gene PDPR 247/247
(100 %)
3 diff
(98.8 %id)
BQ478301 insulinoma, Pancreas .j-u 5447 to 5635 1 to 193   tiling clone, fully sequenced,   193/193
(100 %)
5 diff
(97.5 %id)
BQ478079 insulinoma, Pancreas .j-u 5479 to 5636 158 to 1   fully sequenced,   158/158
(100 %)
3 diff
(98.2 %id)
DT215024 brain .k 1 to 748 1 to 747 S18Y tiling clone,   747/747
(100 %)
2 diff
(99.8 %id)
F05273 brain, total brain .k 8 to 309 1 to 301   tiling clone,   301/301
(100 %)
1 diff
(99.7 %id)
BI007659 kidney_tumor .k 370 to 1036 670 to 4   tiling clone,   663/690
(96 %)
6 diff
(99.2 %id)
F01526 brain, total brain .k 840 to 1066 227 to 1   tiling clone,   227/227
(100 %)
0 diff
(100 %id)
DA773557 brain .l 1 to 585 2 to 586   tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
BQ631781 Pancreas, Purified pancreatic islet .l 865 to 1378 1 to 514   tiling clone,   514/514
(100 %)
3 diff
(99.5 %id)
CR614674 fetal brain .l 1879 to 2740 1 to 862 exact tiling clone,   862/862
(100 %)
0 diff
(100 %id)
BQ632081 Pancreas, Purified pancreatic islet .l 2133 to 2740 613 to 6       608/613
(99 %)
0 diff
(100 %id)
DB325861 brain .l 2171 to 2734 565 to 1       565/565
(100 %)
1 diff
(99.9 %id)
DA089947 cerebellum .m 1 to 277 2 to 278   tiling clone, capped   277/277
(100 %)
0 diff
(100 %id)
BG715433 brain, hypothalamus .m 15 to 813 1 to 805       805/805
(100 %)
19 diff
(97.7 %id)
BI603334 brain, hypothalamus .m 15 to 805 1 to 791       791/792
(99 %)
10 diff
(98.8 %id)
AK054579   .m 20 to 1577 1 to 1558   available from FLJ,   1558/1558
(100 %)
1 diff
(100.0 %id)
TI_45210769   .m 20 to 805 124 to 909       786/910
(86 %)
11 diff
(98.8 %id)
CB106760 Liver .m 20 to 534 1 to 515       515/515
(100 %)
0 diff
(100 %id)
DA000539   .m 21 to 338 2 to 323   capped   322/322
(100 %)
5 diff
(98.5 %id)
DA013360 adrenal gland .m 21 to 437 2 to 418   capped   417/417
(100 %)
1 diff
(99.8 %id)
DA055256 cerebellum .m 21 to 492 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
DA065056 cerebellum .m 21 to 462 2 to 444   capped   443/443
(100 %)
1 diff
(99.8 %id)
DA067626 cerebellum .m 21 to 559 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA113416 cerebellum .m 21 to 614 2 to 595   capped   594/595
(99 %)
4 diff
(99.4 %id)
DA132270 alzheimer cortex .m 21 to 584 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA141032 alzheimer cortex .m 21 to 576 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA518852 brain .m 21 to 323 2 to 306   capped   305/305
(100 %)
6 diff
(98.1 %id)
DA518915 brain .m 21 to 279 2 to 260   capped   259/259
(100 %)
0 diff
(100 %id)
DA684215   .m 21 to 480 2 to 463   capped   462/462
(100 %)
2 diff
(99.6 %id)
DA695699   .m 21 to 279 2 to 260   capped   259/259
(100 %)
0 diff
(100 %id)
DB474824 hippocampus .m 23 to 526 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
DA769893 brain .m 23 to 305 2 to 284   capped   283/283
(100 %)
0 diff
(100 %id)
DA059768 cerebellum .m 25 to 450 2 to 427   capped   426/426
(100 %)
1 diff
(99.8 %id)
DA131825 alzheimer cortex .m 25 to 536 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
DA199077 brain .m 25 to 588 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
TI_57241557   .m 27 to 709 27 to 708       682/712
(95 %)
7 diff
(99.1 %id)
DA516117 brain .m 32 to 470 2 to 445   capped   444/444
(100 %)
6 diff
(98.7 %id)
AW162996 brain, frontal lobe .m 33 to 457 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
CR610620 fetal brain .m 34 to 1576 1 to 1543   tiling clone,   1543/1543
(100 %)
0 diff
(100 %id)
AI928928 brain, frontal lobe .m 34 to 449 1 to 416       416/416
(100 %)
2 diff
(99.6 %id)
AW160509 brain, frontal lobe .m 34 to 463 1 to 430       430/430
(100 %)
2 diff
(99.6 %id)
CN418924 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 36 to 614 1 to 579       579/579
(100 %)
5 diff
(99.2 %id)
CX871423 embryonic stem .m 36 to 735 1 to 700       700/700
(100 %)
0 diff
(100 %id)
BI914536 brain .m 37 to 709 1 to 673       673/677
(99 %)
3 diff
(99.6 %id)
CR610215 fetal brain .m 38 to 1564 1 to 1527       1527/1527
(100 %)
0 diff
(100 %id)
BX461555 brain, fetal brain .m 38 to 855 1 to 817       817/817
(100 %)
9 diff
(98.9 %id)
AL538986 brain, fetal brain .m 38 to 906 1 to 869   fully sequenced,   869/869
(100 %)
7 diff
(99.2 %id)
BI914309 brain .m 39 to 730 1 to 705       705/861
(81 %)
60 diff
(93.1 %id)
TI_57241952   .m 39 to 730 34 to 738       705/894
(78 %)
66 diff
(92.7 %id)
CR598599 adult brain .m 41 to 1559 1 to 1519       1519/1519
(100 %)
0 diff
(100 %id)
CR600224 fetal brain .m 41 to 1576 1 to 1536       1536/1536
(100 %)
0 diff
(100 %id)
BX419462 brain, fetal brain .m 41 to 906 1 to 864   fully sequenced,   864/864
(100 %)
3 diff
(99.7 %id)
BX420465 brain, fetal brain .m 41 to 953 1 to 908       908/916
(99 %)
8 diff
(99.2 %id)
BX442606 brain, fetal brain .m 41 to 906 6 to 868   fully sequenced,   863/868
(99 %)
12 diff
(98.7 %id)
AL532834 adult brain, brain .m 41 to 814 1 to 769   fully sequenced,   769/769
(100 %)
33 diff
(95.8 %id)
AW409769 muscle, rhabdomyosarcoma .m 41 to 528 19 to 506       488/506
(96 %)
6 diff
(98.9 %id)
BQ417418 Pancreas, Purified pancreatic islet .m 42 to 503 18 to 479       462/479
(96 %)
5 diff
(99.0 %id)
CA771528 Pancreas, Purified pancreatic islet .m 42 to 524 4 to 486       483/486
(99 %)
5 diff
(99.0 %id)
CT002853 T-Lymphocytes .m 42 to 476 1 to 435       435/440
(98 %)
5 diff
(98.9 %id)
BF526693 brain, glioblastoma with EGFR amplification .m 44 to 799 1 to 750       750/750
(100 %)
14 diff
(98.2 %id)
BQ898564 brain, neuroblastoma, cell line .m 46 to 723 1 to 679       679/905
(75 %)
8 diff
(99.2 %id)
DB048465 testis .m 46 to 421 2 to 379   capped   378/378
(100 %)
4 diff
(99.0 %id)
BF034024 adenocarcinoma, ovary .m 47 to 721 1 to 686       686/1014
(67 %)
26 diff
(97.5 %id)
CX782950 human embryonic stem cells .m 47 to 724 1 to 678       678/682
(99 %)
4 diff
(99.5 %id)
CX758107 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .m 47 to 721 1 to 673       673/708
(95 %)
16 diff
(97.8 %id)
CN418923 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 48 to 461 1 to 414       414/414
(100 %)
0 diff
(100 %id)
CN418931 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 48 to 462 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
BQ067312 pooled brain, lung, testis .m 48 to 411 1 to 364       364/1332
(27 %)
7 diff
(99.5 %id)
CN418930 embryonic stem cells, cell lines H1, H7, andH9 .m 49 to 328 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
BU159036 large cell carcinoma, lung .m 50 to 658 1 to 612       612/958
(63 %)
13 diff
(98.7 %id)
BU151279 brain, neuroblastoma, cell line .m 51 to 885 1 to 841       841/939
(89 %)
38 diff
(96.0 %id)
CX757746 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .m 58 to 724 1 to 666     Submitted on the opposite strand 666/787
(84 %)
13 diff
(98.4 %id)
CN418925 embryonic stem cells, DMSO-treated H9 cellline .m 60 to 461 1 to 402       402/402
(100 %)
0 diff
(100 %id)
CN418926 embryonic stem cells, cell lines H1, H7, andH9 .m 60 to 502 13 to 455       443/455
(97 %)
6 diff
(98.7 %id)
CR609753 fetal brain .m 62 to 1576 1 to 1515       1515/1515
(100 %)
0 diff
(100 %id)
BX418621 brain, fetal brain .m 62 to 796 1 to 734   fully sequenced,   734/734
(100 %)
1 diff
(99.9 %id)
BI917557 brain .m 62 to 693 1 to 638       638/638
(100 %)
11 diff
(98.3 %id)
TI_57244779   .m 62 to 926 37 to 923       840/925
(90 %)
42 diff
(95.5 %id)
BM894335 insulinoma, Pancreas .m 63 to 387 29 to 353     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 325/353
(92 %)
8 diff
(97.8 %id)
BQ581383.
matches multiple genes
insulinoma, Pancreas .m 63 to 259 7 to 203     Submitted on the opposite strand, also hits gene UBE4AandATP5L 197/208
(94 %)
7 diff
(96.7 %id)
BU070789 insulinoma, Pancreas .m 63 to 459 29 to 426     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 398/427
(93 %)
9 diff
(97.9 %id)
BU072997 insulinoma, Pancreas .m 63 to 462 29 to 428       400/430
(93 %)
7 diff
(98.4 %id)
BU783725 insulinoma, Pancreas .m 63 to 432 29 to 398     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 370/398
(92 %)
6 diff
(98.5 %id)
CX756870 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .m 63 to 583 1 to 521     Submitted on the opposite strand 521/723
(72 %)
13 diff
(98.3 %id)
CX761746 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .m 63 to 624 1 to 560     Submitted on the opposite strand 560/726
(77 %)
15 diff
(98.0 %id)
CN418927 embryonic stem cells, DMSO-treated H9 cellline .m 72 to 180 1 to 109       109/109
(100 %)
0 diff
(100 %id)
CN418928 embryonic stem cells, DMSO-treated H9 cellline .m 72 to 298 1 to 227       227/227
(100 %)
0 diff
(100 %id)
BI116860 lung, small cell carcinoma .m 84 to 725 1 to 643       643/891
(72 %)
13 diff
(98.6 %id)
BI759203 pooled colon, kidney, stomach .m 85 to 976 1 to 901       899/901
(99 %)
20 diff
(97.8 %id)
TI_57146027   .m 85 to 880 68 to 866       799/968
(82 %)
16 diff
(98.4 %id)
BU070117 insulinoma, Pancreas .m 205 to 634 1 to 430     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 430/430
(100 %)
9 diff
(98.0 %id)
BI710780 insulinoma, Pancreas .m 215 to 658 1 to 444     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 444/444
(100 %)
5 diff
(98.9 %id)
CN418929 embryonic stem cells, cell lines H1, H7, andH9 .m 234 to 412 179 to 1     Submitted on the opposite strand 179/179
(100 %)
0 diff
(100 %id)
BU788137 insulinoma, Pancreas .m 461 to 1058 1 to 598   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 598/598
(100 %)
6 diff
(99.0 %id)
AI929753 brain, frontal lobe .m 485 to 950 466 to 1       466/466
(100 %)
3 diff
(99.4 %id)
CR601816 fetal brain .m 535 to 1576 1 to 1042       1042/1042
(100 %)
0 diff
(100 %id)
BX440977 brain, fetal brain .m 535 to 992 1 to 456   fully sequenced,   456/456
(100 %)
14 diff
(97.0 %id)
BX434639 brain, fetal brain .m 766 to 1576 812 to 1 S8F C9L G10W T11H I12N ... fully sequenced,   812/812
(100 %)
4 diff
(99.6 %id)
AL564890 adult brain, brain .m 784 to 1559 774 to 1 N7X G13E K24X E39X E53X ... fully sequenced,   774/774
(100 %)
19 diff
(97.6 %id)
AL567601 brain, fetal brain .m 845 to 1557 720 to 8   fully sequenced,   713/720
(99 %)
0 diff
(100 %id)
BX413740 brain, fetal brain .m 875 to 1576 703 to 1   fully sequenced,   703/703
(100 %)
3 diff
(99.6 %id)
BX455218 brain, fetal brain .m 876 to 1576 702 to 1   fully sequenced,   702/702
(100 %)
20 diff
(97.2 %id)
BX435476 brain, fetal brain .m 880 to 1574 694 to 1       694/871
(79 %)
33 diff
(96.3 %id)
AW157027 brain, frontal lobe .m 888 to 1578 699 to 7   tiling clone,   693/699
(99 %)
5 diff
(99.3 %id)
AW162124 brain, frontal lobe .m 911 to 1574 670 to 7       664/670
(99 %)
1 diff
(99.9 %id)
BU070553 insulinoma, Pancreas .m 911 to 1577 689 to 23   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 667/667
(100 %)
10 diff
(98.6 %id)
BU070984 insulinoma, Pancreas .m 917 to 1572 656 to 1       656/656
(100 %)
0 diff
(100 %id)
BX455043 brain, fetal brain .m 931 to 1576 647 to 1   fully sequenced,   647/647
(100 %)
3 diff
(99.6 %id)
BU069881 insulinoma, Pancreas .m 932 to 1577 661 to 16   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 646/646
(100 %)
1 diff
(99.9 %id)
BI711107 insulinoma, Pancreas .m 960 to 1577 633 to 16   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 618/625
(98 %)
3 diff
(99.6 %id)
BQ549506.
matches multiple genes
insulinoma, Pancreas .m 961 to 1558 602 to 1     Submitted on the opposite strand, also hits gene UBE4AandATP5L 602/622
(96 %)
20 diff
(96.8 %id)
BQ287961 Pancreas, Purified pancreatic islet .m 998 to 1574 579 to 3       577/579
(99 %)
8 diff
(98.7 %id)
BU782730 insulinoma, Pancreas .m 1009 to 1577 590 to 22   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 569/571
(99 %)
7 diff
(98.8 %id)
BU784465 insulinoma, Pancreas .m 1028 to 1577 565 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 550/550
(100 %)
1 diff
(99.9 %id)
DB294930   .m 1044 to 1577 534 to 1       534/534
(100 %)
1 diff
(99.9 %id)
CX782871 human embryonic stem cells .m 1070 to 1578 542 to 34       509/542
(93 %)
0 diff
(100 %id)
BM894063 insulinoma, Pancreas .m 1091 to 1577 510 to 24   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
CA771220 Pancreas, Purified pancreatic islet .m 1125 to 1576 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI929181 brain, frontal lobe .m 1134 to 1574 447 to 7       441/451
(97 %)
0 diff
(100 %id)
AI815652 brain, frontal lobe .n 1 to 376 12 to 387   tiling clone,   382/387
(98 %)
6 diff
(98.5 %id)
DA501306 brain .n 3 to 505 2 to 505   tiling clone, capped   504/506
(99 %)
3 diff
(99.5 %id)
DA510625 brain .n 3 to 565 2 to 564   tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
CN294537 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 16 to 265 1 to 250       250/250
(100 %)
0 diff
(100 %id)
AI879952 brain, frontal lobe .n 553 to 1035 483 to 1   tiling clone,   483/483
(100 %)
0 diff
(100 %id)
DA291234 hippocampus .n 986 to 1524 2 to 541   tiling clone, capped   540/540
(100 %)
2 diff
(99.7 %id)
DA323009 hippocampus .n 1283 to 1837 2 to 555   tiling clone, capped   554/555
(99 %)
2 diff
(99.7 %id)
AK055249 brain .o-u 1 to 2613 2 to 2614 exact tiling clone, available from FLJ,   2614/2618
(99 %)
3 diff
(99.9 %id)
DA483907 brain .o-u 1 to 481 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA356096 subthalamic nucleus .o-u 556 to 965 2 to 413   capped   412/412
(100 %)
5 diff
(98.8 %id)
CX785306 human embryonic stem cells .o-u 722 to 1466 1 to 744       744/744
(100 %)
3 diff
(99.6 %id)
CX757341 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .o-u 1211 to 1914 1 to 695       695/838
(82 %)
20 diff
(97.7 %id)
BQ717423 sympathetic trunk .o-u 1525 to 2318 1 to 808 exact tiling clone,   808/917
(88 %)
25 diff
(97.3 %id)
CA772206 Pancreas, Purified pancreatic islet .o-u 1732 to 2166 11 to 444 N49D fully sequenced,   434/444
(97 %)
9 diff
(98.0 %id)
AA340316 brain .o-u 1943 to 2304 1 to 363       363/363
(100 %)
2 diff
(99.5 %id)
AW952826   .o-u 1944 to 2538 1 to 595       595/598
(99 %)
11 diff
(98.2 %id)
DB315069 brain .o-u 2082 to 2613 537 to 5       533/537
(99 %)
0 diff
(100 %id)
AW974143   .o-u 2091 to 2606 641 to 126   AAA Submitted on the opposite strand 516/517
(99 %)
0 diff
(100 %id)
AA572910 Prostate, prostatic intraepithelial neoplasia - highgrade .o-u 2132 to 2603 493 to 22   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 472/472
(100 %)
3 diff
(99.4 %id)
CA771926 Pancreas, Purified pancreatic islet .o-u 2136 to 2575 440 to 1   fully sequenced,   440/440
(100 %)
0 diff
(100 %id)
DA509174 brain .p-u 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
AB209038 brain Gene UCHL1, variant not shown              
BE267347 lung, small cell carcinoma Gene UCHL1, variant not shown         Suspected internal deletion, this clone was ignored    
217 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o-u, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI